Name
OÜ RNTMEDS
Registry code
14231619
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.03.2017 (7)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment
155 518 €
113 139 €
73%
323 €
(estimate is approximate)
123 471 €
1
Submitted
No tax arrears
92%
89%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Taaniel Laisk 09.02.1989 (35) | 30% - 750.00 EUR | Board member | Direct ownership | Founder |
| Raul Õunapuu 16.02.1990 (34) | 20% - 500.00 EUR | Board member | Direct ownership | |
| Alar Viidalepp 24.07.1991 (33) | 10% - 250.00 EUR | Board member | - | |
| Riina Soo 01.08.1991 (33) | 40% - 1 000.00 EUR | Board member | Direct ownership |
| 2019 16.05.2020 | 2020 16.03.2021 | 2021 11.03.2022 | 2022 17.03.2023 | 2023 23.02.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 84 118 € | 88 389 € | 44 779 € | 112 387 € | 155 518 € |
| Net profit (loss) for the period | 59 945 € | 49 616 € | 21 116 € | 88 447 € | 113 139 € |
| Profit Margin | 71% | 56% | 47% | 79% | 73% |
| Current Assets | 66 874 € | 66 288 € | 37 430 € | 93 198 € | 99 598 € |
| Fixed Assets | - | - | - | - | 27 051 € |
| Total Assets | 66 874 € | 66 288 € | 37 430 € | 93 198 € | 126 649 € |
| Current Liabilities | 1 620 € | 1 053 € | 789 € | 2 251 € | 3 178 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 65 254 € | 65 235 € | 36 641 € | 90 947 € | 123 471 € |
| Employees | 2 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 19 282.63 € | 4 516.48 € | 4 |
| 2023 Q4 | - | 308.07 € | 349.11 € | 4 |
| 2023 Q3 | - | 308.07 € | 349.11 € | 3 |
| 2023 Q2 | - | 19 696 € | 3 463.79 € | 3 |
| 2023 Q1 | - | 308.07 € | 349.11 € | 3 |
| 2022 Q4 | - | 273.84 € | 310.32 € | 3 |
| 2022 Q3 | - | 205.38 € | 232.74 € | 3 |
| 2022 Q2 | - | 8 153.03 € | 2 622.6 € | 2 |
| 2022 Q1 | - | 205.38 € | 232.74 € | 2 |
| 2021 Q4 | - | 205.4 € | 232.78 € | 2 |
| 2021 Q3 | - | 136.92 € | 155.16 € | 2 |
| 2021 Q2 | - | 12 181.09 € | 1 536.7 € | 1 |
| 2021 Q1 | - | 102.69 € | 116.37 € | 1 |
| 2020 Q4 | - | 205.38 € | 232.74 € | 2 |
| 2020 Q3 | - | 61.41 € | 88.77 € | 2 |
| 2020 Q2 | - | 15 350.45 € | 3 649.78 € | 2 |
| 2020 Q1 | - | 1 756.23 € | 1 990.37 € | 2 |
